Melanoma
Steven A. Rosenberg, MD, PhD
National Cancer Institute
Father of Immunotherapy
  • Pioneered the use of adoptive immunotherapy.
  • Chief of Surgery at the National Cancer Institute.
  • Credited with developing the use of IL-2 and immune cells for the treatment of patients with melanoma in a procedure termed adoptive cell transfer.
  • Has shown that expanding immune cells (known as tumor infiltrating lymphocytes) in the lab can be used to treat patients with melanoma.
Program Information:
Nominate
Sponsor
News
Previous Inductees:
2013 | 2014
2015 | 2016
2017 | 2018
Connect: